Advertisement
Screener

ENLIVEN THERAPEUTICS, INC. (ELVN) Form D

ENLIVEN THERAPEUTICS, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2019-03-29: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-03-15; Total offering amount $62,998,708.
  • 2016-04-21: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-04-13; Total offering amount $30,999,971.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2019-03-29Rule 506(b)Equity2019-03-15$62,998,708$44,099,096$18,899,61211
2016-04-21Rule 506(b)Equity2016-04-13$30,999,971$6,000,000$24,999,9717

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
AbCellera Biologics Inc. (ABCL)$3.879B-14.59